Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies.
Niedrist T, Kriegl L, Zurl CJ, Schmidt F, Perkmann-Nagele N, Mucher P, Repl M, Flieder I, Radakovics A, Sieghart D, Radner H, Aletaha D, Binder CJ, Gülly C, Krause R, Herrmann M, Wagner OF, Perkmann T, Haslacher H. Niedrist T, et al. Among authors: binder cj. Clin Chem Lab Med. 2022 Nov 4;61(2):332-338. doi: 10.1515/cclm-2022-0875. Print 2023 Jan 27. Clin Chem Lab Med. 2022. PMID: 36323338 Free article.
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology.
Perkmann T, Mucher P, Ösze D, Müller A, Perkmann-Nagele N, Koller T, Radakovics A, Flieder I, Repl M, Marculescu R, Wolzt M, Wagner OF, Binder CJ, Haslacher H. Perkmann T, et al. Among authors: binder cj. J Clin Virol. 2023 Jan;158:105345. doi: 10.1016/j.jcv.2022.105345. Epub 2022 Nov 25. J Clin Virol. 2023. PMID: 36462465 Free PMC article.
Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria.
Riesenhuber M, Nitsche C, Binder CJ, Schernhammer ES, Stamm T, Jakse F, Anwari E, Hamidi F, Haslacher H, Perkmann T, Hengstenberg C, Zelniker TA. Riesenhuber M, et al. Among authors: binder cj. BMJ Open. 2023 Jan 18;13(1):e063760. doi: 10.1136/bmjopen-2022-063760. BMJ Open. 2023. PMID: 36657754 Free PMC article.
Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity.
Dennis E, Murach M, Blackburn CMR, Marshall M, Root K, Pattarabanjird T, Deroissart J, Erickson LD, Binder CJ, Bekiranov S, McNamara CA. Dennis E, et al. Among authors: binder cj. Front Immunol. 2024 Mar 27;15:1380641. doi: 10.3389/fimmu.2024.1380641. eCollection 2024. Front Immunol. 2024. PMID: 38601144 Free PMC article.
Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner.
Harrison J, Newland SA, Jiang W, Giakomidi D, Zhao X, Clement M, Masters L, Corovic A, Zhang X, Drago F, Ma M, Ozsvar Kozma M, Yasin F, Saady Y, Kothari H, Zhao TX, Shi GP, McNamara CA, Binder CJ, Sage AP, Tarkin JM, Mallat Z, Nus M. Harrison J, et al. Among authors: binder cj. Cardiovasc Res. 2024 Mar 14;120(3):318-328. doi: 10.1093/cvr/cvae027. Cardiovasc Res. 2024. PMID: 38381113 Free PMC article.
212 results